Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
15.54
-0.10 (-0.64%)
At close: Jun 1, 2026, 4:00 PM EDT
15.40
-0.14 (-0.90%)
After-hours: Jun 1, 2026, 6:11 PM EDT
Sotera Health Company Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Sotera Health Company stock has a consensus rating of "Buy" and an average price target of $20.13. The average 1-year stock price forecast is 29.54% higher than the current stock price, while the lowest is $16 (+2.96%) and the highest is $24 (+54.44%).
Price Target: $20.13 (+29.54%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sotera Health Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $24 | Buy | Reiterates | $24 | +54.44% | May 6, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +28.70% | May 6, 2026 |
| Barclays | Barclays | Buy Maintains $18 | Buy | Maintains | $18 | +15.83% | May 6, 2026 |
| William Blair | William Blair | Buy Reiterates $15 → $26 | Buy | Reiterates | $15 → $26 | +67.31% | May 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $24 → $22 | Buy | Reiterates | $24 → $22 | +41.57% | May 4, 2026 |
Financial Forecast
Revenue This Year
1.26B
from 1.16B
Increased by 7.85%
Revenue Next Year
1.33B
from 1.26B
Increased by 5.82%
EPS This Year
0.98
from 0.27
Increased by 263.53%
EPS Next Year
1.07
from 0.98
Increased by 8.92%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1.3B | 1.4B | ||
| Avg | 1.3B | 1.3B | ||
| Low | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 12.8% | 10.7% | ||
| Avg | 7.9% | 5.8% | ||
| Low | 4.1% | 2.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1.05 | 1.13 | ||
| Avg | 0.98 | 1.07 | ||
| Low | 0.93 | 1.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 288.9% | 15.5% | ||
| Avg | 263.5% | 8.9% | ||
| Low | 244.8% | 2.8% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.